首页 | 本学科首页   官方微博 | 高级检索  
检索        

地西他滨治疗骨髓增生异常综合征一例报告
引用本文:高冲,陈宝安,刘苒,徐昕,丁家华,王骏,程坚,赵刚,余正平,宋慧慧,鲍文.地西他滨治疗骨髓增生异常综合征一例报告[J].现代医学,2010,38(2):189-190.
作者姓名:高冲  陈宝安  刘苒  徐昕  丁家华  王骏  程坚  赵刚  余正平  宋慧慧  鲍文
作者单位:1. 东南大学附属中大医院,血液科,江苏,南京,210009
2. 江阴市人民医院,肿瘤血液中心,江苏,江阴,214400
摘    要:地西他滨是目前治疗骨髓增生异常综合征(MDS)的优先用药,但其在中国尚未展开大规模的临床应用,其应用于中国人的疗效及安全性尚未评估.我院对1例MDS患者进行了地西他滨第1个疗程的治疗,取得满意疗效,提示地西他滨在中国具有良好的应用前景.

关 键 词:地西他滨  骨髓增生异常综合征  病例报告

A case report of decitabine treatment of myelodysplastic syndrome
GAO Chong,CHEN Bao-an,LIU Ran,XU Xin,DING Jia-hua,WANG Jun,CHENG Jian,ZHAO Gang,YU Zheng-ping,SONG Hui-hui,BAO Wen.A case report of decitabine treatment of myelodysplastic syndrome[J].Modern Medical JOurnal,2010,38(2):189-190.
Authors:GAO Chong  CHEN Bao-an  LIU Ran  XU Xin  DING Jia-hua  WANG Jun  CHENG Jian  ZHAO Gang  YU Zheng-ping  SONG Hui-hui  BAO Wen
Abstract:Decitabine is now recommended for the treatment of myelodysplastic syndrome(MDS),but its largescale clinical application has not been carried out in China,its efficacy and safety have not been assessed for the Chinese people.We took the first course of decitabine treatment on one patient with MDS,and the efficacy is satisfactory.Revealed that in China,decitabine may has a good application prospects.
Keywords:decitabine  myelodysplastic syndrome  case report  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号